Novel aminoglycoside resistance transposons and transposon-derived circular forms detected in carbapenem-resistant Acinetobacter baumannii clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1801-1818

  Karah, Nabil ^a   Dwibedi, Chinmay Kumar ^a   Sjöström, Karin ^b   Edquist, Petra ^b   Johansson, Anders ^a   Wai, Sun Nyunt ^a   Uhlin, Bernt Eric ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; METHYLTRANSFERASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; BETA-LACTAMASE OXA-24; BETA-LACTAMASE OXA-40, ACINETOBACTER BAUMANNII; CARBAPENEM DERIVATIVE; TRANSPOSON;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SWEDEN; TRANSPOSON; ACINETOBACTER INFECTIONS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; CEFTAZIDIME; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84960080745     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02143-15     Document Type: Article

References (64)

1. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939-951. http://dx.doi.org/10.1038/nrmicro1789.
2. Karah N, Sundsfjord A, Towner K, Samuelsen O. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237-247. http://dx.doi.org/10.1016/j.drup. 2012.06.001.
3. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones fromanancestral susceptible genetic pool. PLoS One 5:e10034. http://dx.doi.org/10.1371/journal.pone.0010034.
4. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
5. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12:826-836. http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x.
6. Hamidian M, Hancock DP, Hall RM. 2013. Horizontal transfer of an ISAba125 activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. J Antimicrob Chemother 68:244-245. http://dx.doi.org/10.1093/jac/dks345.
7. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. 2004. Diversity of aminoglycoside-resistance genes and their association with class1 integrons among strains of pan-EuropeanAcinetobacter baumannii clones. J Med Microbiol 53:1233-1240. http://dx.doi.org/10.1099/jmm.0.45716-0.
8. Nigro SJ, Post V, Hall RM. 2011. Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J Antimicrob Chemother 66:1504-1509. http://dx.doi.org/10.1093/jac/dkr163.
9. Post V, Hall RM. 2009. AbaR5, a large multiple antibiotic resistance region found in Acinetobacter baumannii. Antimicrob Agents Chemother 53:2667-2671. http://dx.doi.org/10.1128/AAC.01407-08.
10. Doi Y, Adams JM, Yamane K, Paterson DL. 2007. Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrob Agents Chemother 51:4209-4210. http://dx.doi.org/10.1128/AAC.00560-07.
11. Doi Y, Arakawa Y. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88-94. http://dx.doi.org/10.1086/518605.
12. Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. 2009. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect Dis 64:185-190. http://dx.doi.org/10.1016/j.diagmicrobio.2009.02.010.
13. Vila J, Ruiz J, Goni P, Jimenez de Anta T. 1997. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 39:757-762. http://dx.doi.org/10.1093/jac/39.6.757.
14. Karah N, Giske CG, Sundsfjord A, Samuelsen O. 2011. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumanniiclinical isolates from Sweden belongingtodifferent international clonal lineages. Microb Drug Resist 17:545-549. http://dx.doi.org/10.1089/mdr.2011.0089.
15. La Scola B, Gundi VA, Khamis A, Raoult D. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 44:827-832. http://dx.doi.org/10.1128/JCM.44.3.827-832.2006.
16. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44:2974-2976. http://dx.doi.org/10.1128/JCM.01021-06.
17. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. Document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114-4123. http://dx.doi.org/10.1128/AAC.00778-06.
19. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355-1361. http://dx.doi.org/10.1128/JCM.06094-11.
20. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresisgenerated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335.2005.
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239.
22. Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJ, Birol I. 2009. ABySS: a parallel assembler for short read sequence data. Genome Res 19:1117-1123. http://dx.doi.org/10.1101/gr.089532.108.
23. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. http://dx.doi.org/10.1093/jac/dks261.
24. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32-D36. http://dx.doi.org/10.1093/nar/gkj014.
25. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54:4168-4177. http://dx.doi.org/10.1128/AAC.00542-10.
26. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39:1201-1203. http://dx.doi.org/10.1128/AAC.39.5.1201.
27. Nigro SJ, Farrugia DN, Paulsen IT, Hall RM. 2013. A novel family of genomic resistance islands, AbGRI2, contributing to aminoglycoside resistance in Acinetobacter baumannii isolates belonging to global clone 2. J Antimicrob Chemother 68:554-557. http://dx.doi.org/10.1093/jac/dks459.
28. Roberts AP, Chandler M, Courvalin P, Guedon G, Mullany P, Pembroke T, Rood JI, Smith CJ, Summers AO, Tsuda M, Berg DE. 2008. Revised nomenclature for transposable genetic elements. Plasmid 60:167-173. http://dx.doi.org/10.1016/j.plasmid.2008.08.001.
29. Zhou H, Zhang T, Yu D, Pi B, Yang Q, Zhou J, Hu S, Yu Y. 2011. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother 55:4506-4512. http://dx.doi.org/10.1128/AAC.01134-10.
30. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50:1442-1448. http://dx.doi.org/10.1128/AAC.50.4.1442-1448.2006.
31. D'Andrea MM, Giani T, D'Arezzo S, Capone A, Petrosillo N, Visca P, Luzzaro F, Rossolini GM. 2009. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 53:3528-3533. http://dx.doi.org/10.1128/AAC.00178-09.
32. Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, Bou G. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother 54:2724-2727. http://dx.doi.org/10.1128/AAC.01674-09.
33. Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. 2014. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 58:2916-2920. http://dx.doi.org/10.1128/AAC.01212-13.
34. Evans BA, Hamouda A, Towner KJ, Amyes SG. 2008. OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 14:268-275. http://dx.doi.org/10.1111/j.1469-0691.2007.01919.x.
35. Lean SS, Yeo CC, Suhaili Z, Thong KL. 2015. Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 clone from Malaysia. Int J Antimicrob Agents 45:178-182. http://dx.doi.org/10.1016/j.ijantimicag.2014.10.015.
36. Saranathan R, Tomar A, Sudhakar P, Arunkumar KP, Prashanth K. 2014. Draft genome sequence of a multidrug-resistant Acinetobacter baumannii PKAB07 clinical strain from India belonging to sequence type 195. Genome Announc 2(2):e00184-14. http://dx.doi.org/10.1128/genomeA.00184-14.
37. Revathi G, Siu LK, Lu PL, Huang LY. 2013. First report of NDM-1-producing Acinetobacter baumannii in East Africa. Int J Infect Dis 17:e1255-e1258. http://dx.doi.org/10.1016/j.ijid.2013.07.016.
38. Bonnin R, Potron A, Poirel L, Lecuyer H. 2011. PER-7, an extendedspectrum β-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 55:2424-2427. http://dx.doi.org/10.1128/AAC.01795-10.
39. Hamidian M, Hall RM. 2014. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. J Antimicrob Chemother 69:77-78. http://dx.doi.org/10.1093/jac/dkt312.
40. Mammeri H, Poirel L, Mangeney N, Nordmann P. 2003. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother 47:1536-1542. http://dx.doi.org/10.1128/AAC.47.5.1536-1542.2003.
41. Opazo A, Sonnevend A, Lopes B, Hamouda A, Ghazawi A, Pal T, Amyes SG. 2012. Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates. J Antimicrob Chemother 67:1619-1622. http://dx.doi.org/10.1093/jac/dks087.
42. Harmer CJ, Moran RA, Hall RM. 2014. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 5:e01801-14. http://dx.doi.org/10.1128/mBio.01801-14.
43. Galimand M, Sabtcheva S, Courvalin P, Lambert T. 2005. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob Agents Chemother 49:2949-2953. http://dx.doi.org/10.1128/AAC.49.7.2949-2953.2005.
44. Gonzalez-Zorn B, Catalan A, Escudero JA, Dominguez L, Teshager T, Porrero C, Moreno MA. 2005. Genetic basis for dissemination of armA. J Antimicrob Chemother 56:583-585. http://dx.doi.org/10.1093/jac/dki246.
45. Cain AK, Liu X, Djordjevic SP, Hall RM. 2010. Transposons related to Tn1696 in IncHI2 plasmids in multiply antibiotic resistant Salmonella enterica serovar Typhimurium from Australian animals. Microb Drug Resist 16:197-202. http://dx.doi.org/10.1089/mdr.2010.0042.
46. Zhu L, Yan Z, Zhang Z, Zhou Q, Zhou J, Wakeland EK, Fang X, Xuan Z, Shen D, Li QZ. 2013. Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements. PLoS One 8:e66584. http://dx.doi.org/10.1371/journal.pone.0066584.
47. Liu CC, Tang CY, Kuo HY, Lu CW, Chang KC, Liou ML. 2013. The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study. Int J Antimicrob Agents 41:318-324. http://dx.doi.org/10.1016/j ijantimicag.2012.12.010.
48. Huang H, Yang ZL, Wu XM, Wang Y, Liu YJ, Luo H, Lv X, Gan YR, Song SD, Gao F. 2012. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. J Antimicrob Chemother 67:2825-2832. http://dx.doi.org/10.1093/jac/dks327.
49. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout J. 2013. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57:3085-3091. http://dx.doi.org/10.1128/AAC.00297-13.
50. Segal H, Elisha BG. 1997. Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. FEMS Microbiol Lett 153:321-326. http://dx.doi.org/10.1111/j.1574-6968.1997.tb12591.x.
51. Gifford B, Tucci J, McIlroy SJ, Petrovski S. 2014. Isolation and characterization of two plasmids in a clinical Acinetobacter nosocomialis strain. BMC Res Notes 7:732. http://dx.doi.org/10.1186/1756-0500-7-732.
52. Hamidian M, Nigro SJ, Hall RM. 2012. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother 67:2833-2836. http://dx.doi.org/10.1093/jac/dks318.
53. Anba J, Bidnenko E, Hillier A, Ehrlich D, Chopin MC. 1995. Characterization of the lactococcal abiD1 gene coding for phage abortive infection. J Bacteriol 177:3818-3823.
54. Haines AS, Jones K, Batt SM, Kosheleva IA, Thomas CM. 2007. Sequence of plasmid pBS228 and reconstruction of the IncP-1α phylogeny. Plasmid 58:76-83. http://dx.doi.org/10.1016/j.plasmid.2007.01.001.
55. Tennstedt T, Szczepanowski R, Krahn I, Pühler A, Schlüter A. 2005. Sequence of the 68, 869 bp IncP1α plasmid pTB11 from a waste water treatment plant reveals a highly conserved backbone, a Tn402-like integron and other transposable elements. Plasmid 53:218-238. http://dx.doi.org/10.1016/j.plasmid.2004.09.004.
56. Vincent AT, Trudel MV, Paquet VE, Boyle B, Tanaka KH, Dallaire-Dufresne S, Daher RK, Frenette M, Derome N, Charette SJ. 2014. Detection of variants of the pRAS3, pAB5S9, and pSN254 plasmids in Aeromonas salmonicida subsp. salmonicida: multidrug resistance, interspecies exchanges, and plasmid reshaping. Antimicrob Agents Chemother 58:7367-7374. http://dx.doi.org/10.1128/AAC.03730-14.
57. Domingues S, Harms K, Fricke FW, Johnsen PJ, da Silva G, Nielsen KM. 2012. Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species. PLoS Pathog 8:e1002837. http://dx.doi.org/10.1371/journal.ppat.1002837.
58. Coetzee JN, Datta N, Hedges RW. 1972. R factors from Proteus rettgeri. J Gen Microbiol 72:543-552. http://dx.doi.org/10.1099/00221287-72-3-543.
59. He T, Wang Y, Qian M, Wu C. 2015. Mequindox resistance and in vitro efficacy in animal-derived Escherichia coli strains. Vet Microbiol 177:341-346. http://dx.doi.org/10.1016/j.vetmic.2015.04.007.
60. Wang Y, He T, Schwarz S, Zhou D, Shen Z, Wu C, Wang Y, Ma L, Zhang Q, Shen J. 2012. Detection of the staphylococcal multiresistance gene cfr in Escherichia coli of domestic-animal origin. J Antimicrob Chemother 67:1094-1098. http://dx.doi.org/10.1093/jac/dks020.
61. Lambert T, Gerbaud G, Courvalin P. 1988. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase. Antimicrob Agents Chemother 32:15-19. http://dx.doi.org/10.1128/AAC.32.1.15.
62. OXA-58 in Acinetobacter spp. from multiple cities in China. PLoS One 9:e84680. http://dx.doi.org/10.1371/journal.pone.0084680.
63. Liu CC, Kuo HY, Tang CY, Chang KC, Liou ML. 2014. Prevalence and mappingof a plasmid encodingatypeIVsecretion system in Acinetobacter baumannii. Genomics 104:215-223. http://dx.doi.org/10.1016/j.ygeno. 2014.07.011.
64. Nigro SJ, Holt KE, Pickard D, Hall RM. 2015. Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid. J Antimicrob Chemother 70:1259-1261. http://dx.doi.org/10.1093/jac/dku486.